Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SACRED: Stroke Avoidance for Children in Dominican Republic
NCT02769845Completed
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Mar 2016
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of hydroxyurea in sickle cell anemia (SCA) (2 arms), sponsored by Cincinnati Children's Hospital Medical Center. Primary endpoint: Transcranial Doppler Ultrasound examinations. Started Mar 2016; status: completed.
02
Drugs
hydroxyurea
03
Conditions
sickle cell anemia (SCA)
Beyond the preview
Go deeper on NCT02769845.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02769845.